Patients with advanced pancreatic and biliary cancer appear vulnerable to SARS-CoV-2 Omicron variant: An observational study during the COVID-19 outbreak in Shanghai

BACKGROUND: The COVID-19 pandemic has spread rapidly across the globe. Cancer patients have a higher risk of severe infections and associated mortality than the general population. However, the lethal effect of Omicron-variant affection on advanced pancreatic and biliary cancer patients is still not...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Tao, Chen, Lujun, Gu, Jia, Wu, Shen, Maihemuti, Maiweilan, Yang, Jue, Wang, Hao, Wu, Jun, Zhang, Yue, Cong, Yun, Wang, Jiening, Chen, Tingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073743/
https://www.ncbi.nlm.nih.gov/pubmed/37035158
http://dx.doi.org/10.3389/fonc.2023.1115293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073743/
https://www.ncbi.nlm.nih.gov/pubmed/37035158
http://dx.doi.org/10.3389/fonc.2023.1115293

Ejemplares similares